Dianthus Therapeutics, Inc.DNTHNASDAQ
LOADING
|||
EV to Sales: Premium Valuation
Trending higher, above historical average.
Left:
||||
Enterprise value to sales ratio
Latest
113.06
↑ 526% above average
Average (8y)
18.06
Historical baseline
Range
High:113.06
Low:-27.65
Volatility
779.1%
High variability
| Period | Value | Change |
|---|---|---|
| 2024 | 113.06 | +508.9% |
| 2023 | -27.65 | -2048.8% |
| 2022 | 1.42 | -98.1% |
| 2021 | 75.73 | - |
| 2020 | 0.00 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |